Monaco Asset Management’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Sell |
395,000
-21,468
| -5% | -$58.2K | 0.19% | 48 |
|
|
2025
Q1 | $937K | Buy |
416,468
+35,000
| +9% | +$78.8K | 0.19% | 44 |
|
|
2024
Q4 | $1.34M | Sell |
381,468
-3,067
| -0.8% | -$10.7K | 0.19% | 40 |
|
|
2024
Q3 | $1.58M | Buy |
384,535
+36,407
| +10% | +$150K | 0.23% | 35 |
|
|
2024
Q2 | $1.25M | Sell |
348,128
-56,872
| -14% | -$205K | 0.2% | 31 |
|
|
2024
Q1 | $1.34M | Sell |
405,000
-271,494
| -40% | -$896K | 0.4% | 33 |
|
|
2023
Q4 | $1.56M | Buy |
676,494
+80,765
| +14% | +$187K | 0.46% | 41 |
|
|
2023
Q3 | $768K | Sell |
595,729
-110,000
| -16% | -$142K | 0.23% | 43 |
|
|
2023
Q2 | $932K | Sell |
705,729
-610,516
| -46% | -$806K | 0.26% | 41 |
|
|
2023
Q1 | $930K | Sell |
1,316,245
-733,416
| -36% | -$518K | 0.29% | 40 |
|
|
2022
Q4 | $1.54M | Buy |
2,049,661
+1,863,005
| +998% | +$1.4M | 0.46% | 38 |
|
|
2022
Q3 | $161K | Buy |
+186,656
| New | +$161K | 0.06% | 62 |
|